ENVALITH
イノバセル株式会社 logo

Innovacell Inc.

504AGrowth MarketPharmaceuticals

イノバセル株式会社 logo
Innovacell Inc.504A
Reference Indicators

Market Cap

209¥100M

P/E (Forecast)

P/B

Dividend Yield (Forecast)

0.00%

ROE

150.2%

EV/EBITDA

Financial Summary
Unit: ¥M
Item
2025Dec 2025
Operating Income
-2,231
Non-operating Income
278
Non-operating Expenses
900
Ordinary Income
-2,853
Pre-tax Income
-2,853
Income Taxes
1
Net Income
-2,855
EBITDA
-2,167
ROA
-56.1%
ROE
150.2%